Translational Neuroscience and Overweight, McKnight Brain Institute, University of Florida, USA
Received Date: 20/07/2023; Published Date: 11/12/2023
*Corresponding author: James A Cocores, MD, Adjunct Assistance Professor, Translational Neuroscience and Overweight, McKnight Brain Institute, University of Florida, 2008-2010, 4611 S Congress Ave, Lake Worth, FL, 33461, USA
Atopic or allergic march often originates early in life and extends throughout adulthood. Food allergy, eczema, hay fever, and asthma denote responses to Immunoglobulin E (IgE). Additional algorithms differentiating food allergies are IgE-mediated, non-IgE-mediated, or mixed [1]. Other players include cross-linking of basophil and mast cell-bound IgE, releasing inflammatory intermediaries, chronic inflammation, and activating T-cells, basophils, and eosinophils [2]. A detailed understanding must precisely uncover the cellular, mitochondrial, and molecular culprit launching food allergy [3]. No cure exists for egg, fish, milk, nuts, peanut legumes, soy, and wheat allergies [4].
Dietary Maillard-reaction end-products (MEs) are associated with asthma [5], hay fever [6], eczema [7], and food allergies [8]. And common food allergens such as eggs, fish, milk, nuts, peanut legumes, soy, and wheat contain very high levels of phosphorous [9]. Phosphorous-rich dietary MEs trigger the degradation of immune-strengthening glutamine to immune-weakening glutamate [10, 11]. Instantly signaling mitochondrial and systemic oxidative stress and immune disharmony.
Therefore, there exists sufficient evidence to implicate dietary MEs as allergens underlying food allergies. A novel way to prevent and treat food allergies may include a period of ME-free, raw, steamed, fondue, boiled, and stewed low phosphorus-containing organic and grass-fed foods and filtered water.
Acknowledgments: The author is thankful to each contributor to the reference list. This article was only possible with their industrious and diligent research efforts.
Conflict of interest statement: The author has no conflicts to disclose.
Funding: None